Item 9 Labs Corp (INLB)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Item 9 Labs Cash and Short Term Investments (Quarterly): 0.1834M for June 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.1834M |
| March 31, 2023 | 0.1012M |
| December 31, 2022 | 0.0218M |
| September 30, 2022 | 0.0856M |
| June 30, 2022 | 0.4417M |
| March 31, 2022 | 0.1051M |
| December 31, 2021 | 0.1607M |
| September 30, 2021 | 1.454M |
| June 30, 2021 | 0.2969M |
| March 31, 2021 | 4.308M |
| December 31, 2020 | 1.614M |
| September 30, 2020 | 0.0847M |
| June 30, 2020 | 0.5647M |
| March 31, 2020 | 0.3043M |
| December 31, 2019 | 0.0467M |
| September 30, 2019 | 0.0211M |
| June 30, 2019 | 0.7868M |
| September 30, 2018 | 0.1743M |
| March 31, 2018 | 1.001M |
| December 31, 2017 | 0.0468M |
| September 30, 2017 | 0.0139M |
| June 30, 2017 | 0.0184M |
| March 31, 2017 | 0.0345M |
| Date | Value |
|---|---|
| December 31, 2016 | 0.0369M |
| September 30, 2016 | 0.0267M |
| June 30, 2016 | 0.009M |
| March 31, 2016 | 0.0437M |
| December 31, 2015 | 0.0266M |
| September 30, 2015 | 0.0417M |
| June 30, 2015 | 0.0354M |
| March 31, 2015 | 0.0491M |
| December 31, 2014 | 0.0777M |
| September 30, 2014 | 0.0426M |
| June 30, 2014 | 0.0779M |
| March 31, 2014 | 0.0803M |
| December 31, 2013 | 0.0967M |
| September 30, 2013 | 0.0199M |
| June 30, 2013 | 0.0291M |
| March 31, 2013 | 0.0878M |
| December 31, 2012 | 0.0489M |
| June 30, 2012 | 0.0141M |
| March 31, 2012 | 0.2049M |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.0003M |
| December 31, 2010 | 0.0003M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.0211M
Minimum
Sep 2019
4.308M
Maximum
Mar 2021
0.6224M
Average
0.1834M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Humanigen Inc | 3.096M |
| Cantabio Pharmaceuticals Inc | 0.2834M |
| Affymax Inc | -- |
| RVL Pharmaceuticals PLC | 19.16M |
| Scopus BioPharma Inc | 0.3621M |